IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Unrecognised Obstructive Sleep Apnea Study (OSA)
This study is ongoing, but not recruiting participants.
Sponsor:
University Health Network, Toronto
Information provided by (Responsible Party):
Dr. Frances Chung, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01494181
First received: December 12, 2011
Last updated: May 4, 2017
Last verified: May 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Plan of investigation:
This is an observational cohort study to determine the effect of OSA, independent of other risk factors, on postoperative vascular events. The study is conceived, designed and will be conducted, and analyzed independent to any company. There is no commercial sponsorship.
| Condition |
|---|
| Obstructive Sleep Apnea |
| Study Type: | Observational |
| Study Design: | Observational Model: Other Time Perspective: Prospective |
| Official Title: | Postoperative Vascular Events in Unrecognised Obstructive Sleep Apnea |
Resource links provided by NLM:
Further study details as provided by Dr. Frances Chung, University Health Network, Toronto:
Primary Outcome Measures:
- primary outcome of this study is postoperative vascular event within 30 days after surgery [ Time Frame: 30 days ]
| Enrollment: | 400 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | December 2018 |
| Estimated Primary Completion Date: | December 2018 (Final data collection date for primary outcome measure) |
The potential study subjects will be approached by study coordinator at preoperative clinic. If the patient is interested in participating the study, he/she will be screened and consented. Undetected or untreated OSA will be established by STOP-Bang questionnaire and subsequent overnight PSG by using Apnea Link Plus which is level ( 2 ) at patient's home.The following data will be recorded: including age, gender, history of coronary artery disease, prior revascularization, cerebrovascular disease, peripheral vascular disease, critical aortic valvular stenosis, congestive heart failure, atrial fibrillation, diabetes treated with insulin or an oral diabetic drug, hypertension, hypercholesterolemia treated with drug therapy, tobacco use, renal insufficiency and the type of surgery. For all study patients, the nocturnal blood oxygen saturation will be monitored by a pulse oximeter (PULSOX 300i) for first 3 nights postoperatively.During their stay in hospital, patients will be followed daily, and outcomes will be recorded, until discharge.. ECG will be measured preoperatively and repeated on day 1 to 3 after surgery. Venous blood will be collected 6-12 hours and on the first 3 days after surgery for measuring cTnT concentration.If patient's ECG is abnormal and/or patient is positive for troponin test, treating physician will be contacted for further treatment. Patient will be contacted 30 days after surgery by phone to ascertain if they have experienced any adverse out come.
Eligibility| Ages Eligible for Study: | 45 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Surgical patient
Criteria
Patients Inclusion & Exclusion Criteria:
Inclusion criteria:
Ethics Committee approval and informed consent will be obtained. We plan to study patients at moderate-to-high risk for postoperative vascular complications because our data from other trials suggested that the incidence of OSA in these patients is higher than the general population. We will include patients who are:
- adult males and females, age ≥ 45 years, undergoing elective non-cardiac surgery that is expected to require a postoperative hospital stay of more than 3 nights, and
- at increased risk for postoperative vascular events, defined as having at least one of the following risk factors (a) high-risk surgery (intra-peritoneal, intra-thoracic or supra-inguinal vascular surgery); (b) history of ischemic heart disease; (c) history of congestive heart failure; (d) history of cerebrovascular disease (d) diabetes requiring insulin therapy (e) serum creatinine > 175 µmol/L.
Exclusion criteria:
Patients will be excluded if:
- they have a previous diagnosis of OSA or any sleep-related breathing disorder and on treatment
- they are unwilling or physically unavailable for PSG on any night before surgery;
- their surgery included tonsillectomy, septoplasty, uvuloplasty, pharyngoplasty, tracheostomy, or prolonged (> 48 hrs) postoperative mechanical ventilation of the lungs is anticipated. It is because these procedures/interventions are likely to cure or at least modify the severity of OSA.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01494181
Please refer to this study by its ClinicalTrials.gov identifier: NCT01494181
Locations
| Canada, Ontario | |
| The Scarborough hospital | |
| Scarborough, Ontario, Canada | |
| Hong Kong | |
| Prince of Wales Hospital | |
| Shatin, Hong Kong | |
| Malaysia | |
| Unversity Malaya Medical Centre | |
| Kuala Lumpur, Malaysia | |
| Singapore | |
| Khoo Teck Puat Hospital | |
| Yishun, Singapore, 768828 | |
Sponsors and Collaborators
University Health Network, Toronto
Investigators
| Principal Investigator: | Frances Chung, MBBS, FRCPC | University Health Network, Toronto |
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr. Frances Chung, Staff Anesthesiologist, University Health Network, Toronto |
| ClinicalTrials.gov Identifier: | NCT01494181 History of Changes |
| Other Study ID Numbers: |
Version Nov 14, 2011 |
| Study First Received: | December 12, 2011 |
| Last Updated: | May 4, 2017 |
Keywords provided by Dr. Frances Chung, University Health Network, Toronto:
|
obstructive sleep apnea vascular events |
Additional relevant MeSH terms:
|
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases |
ClinicalTrials.gov processed this record on September 21, 2017